No. |
Product Name |
CAS No. |
Spec |
Price |
|
| QA011508 |
Anastrozole USP Related Compound A |
120511-72-0 |
|
|
| QA011503 |
Anastrozole USP Related Compound D |
120511-84-4 |
| 25mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QA011504 |
Anastrozole USP Related Compound E |
1027160-12-8 |
| 10mg |
Inquiry |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QP151261 |
(S)-Propranolol HCl |
4199-10-4 |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QP151262 |
(R)-Propranolol HCl |
13071-11-9 |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QR200921 |
Retigabine impurity 1 |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QR200922 |
Retigabine impurity 2 |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QF032021 |
Febuxostat impurity 1 |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QF032022 |
Febuxostat impurity 2 |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QA090221 |
Apixaban impurity 1 (BMS-591455) |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QA090222 |
Apixaban impurity 2 (BMS-724914) |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QA090223 |
Apixaban impurity 3 (BMS-778960) |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QA090224 |
Apixaban impurity 4 (BMS-728626) |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| QA090225 |
Apixaban impurity 5 (BMS-591329) |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| QA090226 |
Apixaban impurity 6 (BMS-719288) |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| QA090227 |
Apixaban impurity 7 (BMS-589145) |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| QL222021 |
Lovastatin Dimer |
149756-62-7 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| TA-024 |
Azithromycin dihydrate ≥95.0% |
117772-70-0 |
|
|
| TA-074 |
Azithromycin impurity E |
612069-27-9 |
|
|
| TA-075 |
Azithromycin impurity F (3’-N-demethyl-3’-N- formylazithromycin) |
612069-28-0 |
|
|
